Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 September 2025 | Story Reuben Maeko | Photo Sizwe Gwiba
Dermatology Unit
Celebrating the milestone launch of the Dermatologic Surgery Unit at Universitas Academic Hospital, a new chapter for advanced patient care, training, and research.

The Department of Dermatology in the Faculty of Health Sciences at the University of the Free State (UFS) marked a historic milestone with the official opening of the Dermatologic Surgery Unit at Universitas Academic Hospital on 11 September 2025. This new facility represents a significant step forward in expanding access to specialised surgical treatment for complex dermatological conditions, while simultaneously strengthening academic training and research opportunities for registrars and medical students.

The inauguration was attended by Prof Francois P Retief, a distinguished medical pioneer from the UFS Faculty of Health Sciences, after whom one of the faculty buildings is named. His wife, Ria Retief, extended words of gratitude and gifted a book from his medical library to Prof Frans Maruma, Head of the Department of Dermatology.

“We are truly honoured to be included in this significant milestone and to witness the beginning of what we know will be an impactful journey aimed at improving patient care,” Ria Retief said. “It is a privilege to celebrate this remarkable achievement with you, and we deeply admire your dedication and vision.”

 

Honouring a legacy in dermatology

In his opening address, Prof Maruma reflected on the journey that led to the establishment of the Dermatologic Surgery Unit, acknowledging the teamwork, persistence, and collaboration that made the vision a reality.

“The Derm-Surgery Unit is not just a surgical space – it is a testament to teamwork, perseverance, and the drive to advance patient-centred care in dermatology,” he said. “We pay homage to visionary leadership that has afforded us the opportunity to expand dermatology services to include surgery and as a skill sacrosanct to modern practice. This is not only about healing, but also about preparing our registrars for the realities of clinical practice through work-integrated learning.”

Prof Maruma extended appreciation to colleagues and staff members in the Department of Dermatology, as well as strategic partners in the UFS, the Department of Health, the pharmaceutical industry, and private practitioners who dedicate their time to teaching and mentoring. Special acknowledgement was given to Dr Marc Roscher, Dr Harriet Makuru, and Dr Yashica Khalawan, who played a pivotal role in supporting the project’s launch.

The programme also included remarks by senior academic leaders. Prof Alicia Sherriff, Acting Head of the School of Clinical Medicine, commended the department for its innovation and foresight in the face of resource limitations, highlighting the potential for further expansion through collaboration with both public and private stakeholders.

While cutting the ribbon, Prof Thabiso Mofokeng, Head of Internal Medicine at Universitas Academic Hospital, emphasised that the launch of the Derm-Surgery Unit reflects the broader ethos of the clinical platform: to enable world-class training, foster research excellence, and deliver quality healthcare that is responsive to the needs of the community.

The launch underscored the university’s commitment to Work-Integrated Learning (WIL), bridging the gap between academic training and real-world clinical demands. The Derm-Surgery initiative is designed to equip registrars with essential industry-specific skills in procedural dermatology while fostering collaboration between private and public healthcare sectors. The evening concluded with awards recognising individuals whose contributions ensured the success of this landmark opening.

Looking ahead, the Department of Dermatology envisions its Derm-Surgery Unit as more than just a clinical unit – it is set to become a hub of advanced patient care, high-impact training, and cutting-edge research. This initiative strengthens the UFS Faculty of Health Sciences’ role as a leader in medical education and healthcare innovation in the Free State and beyond.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept